From April 1, 2024 to June 30, 2024, the company has repurchased 662,150 shares, representing 0.37% for CNY 15.39 million. With this, the company has completed the repurchase of 662,150 shares, representing 0.37% for CNY 15.39 million under the buyback announced on December 20, 2023.
Yantai Zhenghai Biotechnology Co., Ltd.
Equities
300653
CNE100002NZ1
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.82 CNY | +1.72% | +8.18% | -24.81% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.81% | 532M | |
+13.31% | 129B | |
+1.99% | 12.29B | |
-19.52% | 7B | |
+55.28% | 6.73B | |
-32.41% | 4.03B | |
+8.95% | 3.47B | |
-17.98% | 2.51B | |
-18.35% | 1.91B | |
-26.90% | 1.62B |
- Stock Market
- Equities
- 300653 Stock
- News Yantai Zhenghai Biotechnology Co., Ltd.
- Tranche Update on Yantai Zhenghai Biotechnology Co., Ltd.'s Equity Buyback Plan announced on December 20, 2023.